Categoría: Stem Cell Research
-
Medistem Inc. Annual Letter to Shareholders
SAN DIEGO, CA–(Marketwire – Jan 4, 2013) – Medistem Inc. ( PINKSHEETS : MEDS ) today issues the following letter to shareholders. Dear Fellow Shareholders, 2012 was marked by significant progress in the development of the Endometrial Regenerative Cell (ERC), our new universal donor «stem cell drug.» Most significantly, we initiated a double blind, placebo…
-
Could Metabolic Syndrome, Lipodystrophy, and Aging Be Mesenchymal Stem Cell Exhaustion Syndromes?
Eduardo Mansilla,1,* Vanina Díaz Aquino,1 Daniel Zambón,2 Gustavo Horacio Marin,1 Karina Mártire,1 Gustavo Roque,1 Thomas Ichim,3 Neil H. Riordan,3 Amit Patel,4 Flavio Sturla,5 Gustavo Larsen,6, 7 Rubén Spretz,6, 7 Luis Núñez,8, 9 Carlos Soratti,10 Ricardo Ibar,10 Michiel van Leeuwen,11 José María Tau,1 Hugo Drago,5 and Alberto Maceira1 Abstract One of the most important and complex…
-
Medistem Advances Type 1 Diabetes Stem Cell Technology Licensed From Yale
SAN DIEGO, CA — (Marketwire) — 09/12/12 — Medistem Inc. (PINKSHEETS: MEDS) announced today completion of the first phase of a joint project with the Shumakov Research Center of Transplantology and Artificial Organs of the Russian Federation and its Russian and CIS licensee ERCell. The collaboration is based on using Endometrial Regenerative Cell (ERC) technology…
-
Blood Stem Cells Permanently Damaged by Alcohol
Bone marrow stem cells are extremely sensitive to the primary by-product of alcohol, which causes permanent damage to their DNA claims researchers from the Medical Research Council (MRC) Lab of Molecular Biology. The research, which was conducted on mice, uncovers two mechanisms that normally control this type of damage; a protein group that recognizes and…
-
Mesenchymal Stem Cells Stop Arthritis in its Tracks – Duke University
Researchers at Duke University announced a promising new stem cell therapy aimed at osteoarthritis prevention after a joint injury. The probability of developing arthritis after injury (post-traumatic arthritis – PTA) greatly increases after injury. Currently, the US FDA has not approved any drugs that slow or eliminate the progression of PTA. However, at Duke researchers…
-
Endometrial Stem Cells Yeild Postive Clinical Trial Results for Heart Disease
More progress reported on the treatment of heart disease with endometrial stem cells. Neil Riordan, PhD is one of the early pioneers of endometrial stem cell technology. Dr. Riordan is also the Founder and President of the Stem Cell Institute in Panama City, Panama. Positive Two-Month Data From RECOVER-ERC Congestive Heart Failure Trial SAN DIEGO,…
-
Fat Stem Cells are not affected by weight or age
Mojallal et al. Aesthetic Plast Surg. Fat represents a potent source of autologous stem cells. Historically, the majority of research using autologous stem cells involved stem cells collected from the bone marrow. This source is associated with a painful extraction procedure and relatively low concentrations of mesenchymal stem cells. In contract, mini-liposuctions represent a less…
-
Multiple Sclerosis Treatment Success Using Mesenchymal Stem Cell-Secreted Factors in Animal Model
Stem cell researchers at Case Western Reserve have reported in Nature Magazine that the functional deficits caused by multiple sclerosis can be reduced by administering mesenchymal stem cell secreted factors. While previous studies have shown promising results using mesenchymal stem cells, this is the first time that such results have been reported without using the…
-
Adult Stem Cell Therapy Successfully Treats Spinal Cord Injury
An interesting spinal cord injury study was published last week. The Turkish researchers tested two types of stem cells on spinal cord injured mice. The two cell types were native bone marrow cells and cultured repair stem cells called Mesenchymal stem cells. Native bone marrow cells contain bone marrow forming stem cells as well as…